168 related articles for article (PubMed ID: 35566164)
1. Synthesis and Evaluation of Serinolamide Derivatives as Sphingosine-1-Phosphate-1 (S1P
Park SJ; Kim J; Kim J; Kim Y; Lee EH; Kim HJ; Kim S; Kim B; Kim R; Choi JW; Park JH; Park KD
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566164
[TBL] [Abstract][Full Text] [Related]
2. ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P
Stepanovska Tanturovska B; Zivkovic A; Imeri F; Homann T; Kleuser B; Stark H; Huwiler A
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500564
[TBL] [Abstract][Full Text] [Related]
3. Morpholino Analogues of Fingolimod as Novel and Selective S1P
Stepanovska B; Zivkovic A; Enzmann G; Tietz S; Homann T; Kleuser B; Engelhardt B; Stark H; Huwiler A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899717
[TBL] [Abstract][Full Text] [Related]
4. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
5. Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P
Dyckman AJ
J Med Chem; 2017 Jul; 60(13):5267-5289. PubMed ID: 28291340
[TBL] [Abstract][Full Text] [Related]
6. ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile.
Yamamoto R; Okada Y; Hirose J; Koshika T; Kawato Y; Maeda M; Saito R; Hattori K; Harada H; Nagasaka Y; Morokata T
PLoS One; 2014; 9(10):e110819. PubMed ID: 25347187
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Tetrahydroisoquinoline- and Benzo[
Cha E; Kim J; Gotina L; Kim J; Kim HJ; Seo SH; Park JE; Joo J; Kang M; Lee J; Hwang H; Kim HJ; Pae AN; Park KD; Park JH; Lim SM
J Med Chem; 2023 Aug; 66(15):10381-10412. PubMed ID: 37489798
[TBL] [Abstract][Full Text] [Related]
9. Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P
Alizadeh AA; Jafari B; Dastmalchi S
J Mol Graph Model; 2020 Jan; 94():107459. PubMed ID: 31589999
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Guerrero M; Urbano M; Roberts E
Expert Opin Ther Pat; 2016; 26(4):455-70. PubMed ID: 26947494
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Groves A; Kihara Y; Chun J
J Neurol Sci; 2013 May; 328(1-2):9-18. PubMed ID: 23518370
[TBL] [Abstract][Full Text] [Related]
13. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate.
Yonesu K; Nakamura T; Mizuno Y; Suzuki C; Nagayama T; Satoh S; Nara F
Biol Pharm Bull; 2010; 33(9):1500-5. PubMed ID: 20823564
[TBL] [Abstract][Full Text] [Related]
14. Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective Against Ischemia/Reperfusion in Mice.
Brait VH; Tarrasón G; Gavaldà A; Godessart N; Planas AM
Stroke; 2016 Dec; 47(12):3053-3056. PubMed ID: 27827329
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
Chun J; Hartung HP
Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
[TBL] [Abstract][Full Text] [Related]
16. S1P
Birker-Robaczewska M; Bolli M; Rey M; de Kanter R; Kohl C; Lescop C; Boucher M; Poirey S; Steiner B; Nayler O
Mol Pharmacol; 2018 Feb; 93(2):109-118. PubMed ID: 29203519
[TBL] [Abstract][Full Text] [Related]
17. S1P
Martínez-Morales JC; Romero-Ávila MT; Reyes-Cruz G; García-Sáinz JA
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30366961
[TBL] [Abstract][Full Text] [Related]
18. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis.
Chiba K; Adachi K
Pharmaceuticals (Basel); 2012 May; 5(5):514-28. PubMed ID: 24281561
[TBL] [Abstract][Full Text] [Related]
20. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.
Mullershausen F; Zecri F; Cetin C; Billich A; Guerini D; Seuwen K
Nat Chem Biol; 2009 Jun; 5(6):428-34. PubMed ID: 19430484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
